Neurology - European Medical Journal

Continue

Neurology

1 Mins
1st March 2024

Ketamine Proves Effective in Treating Status Epilepticus

Ketamine may be used as an effective treatment for refractory status epilepticus and super-RSE that does not respond to usual treatments, according to recent research.
5 Mins
15th February 2024

Interview: Chia-Chun Chiang

My father, a dedicated neurosurgeon, played a significant role in my choice. He tirelessly shared stories of the lives he had saved…
15th February 2024

Unlocking Autism Spectrum Disorder โ€“ Part 2

Geraldine Dawson discusses datasets, algorithms, and biomarkers in early autism detection.
8th February 2024

Unlocking Autism Spectrum Disorder - Part 1

Geraldine Dawson joins us to provide insight into the onset and characteristics of autism spectrum disorder.
6th February 2024

Understanding LGS Diagnosis in Adulthood: Transatlantic Perspectives

In this insightful podcast, experts explore the identification, diagnosis, and management of LGS in both children and adults based on their experiences in real-life clinical settings.
25th January 2024

Myasthenia Gravis Physiopathology: Relevance to Clinical Practice

View our latest infographic, which provides updates on the physiopathology of myasthenia gravis (MG) and the mechanisms behind its different subtypes.
1 Mins
18th January 2024

Is Vagus Nerve Stimulation Surgery Safe?

Vagus nerve stimulation is the most frequently employed neuromodulation treatment for patients with drug-resistant-epilepsy, but safety profiles have varied across studies.
18th January 2024

ECTRIMS 2023 Symposium: The Latest Developments in MS Classification and Treatment: From AI to Clinical Decision Making

The Latest Developments in MS Classification and Treatment: From AI to Clinical Decision Making, a BMS-promotional Symposium ECTRIMS 2023, presents a thought-provoking view on the latest developments in the field of Multiple Sclerosis. ๐—™๐—ผ๐—ฟ ๐—›๐—ฒ๐—ฎ๐—น๐˜๐—ต๐—ฐ๐—ฎ๐—ฟ๐—ฒ ๐—ฃ๐—ฟ๐—ผ๐—ณ๐—ฒ๐˜€๐˜€๐—ถ๐—ผ๐—ป๐—ฎ๐—น๐˜€ ๐—ผ๐—ป๐—น๐˜†. ๐—ง๐—ต๐—ถ๐˜€ ๐˜€๐˜†๐—บ๐—ฝ๐—ผ๐˜€๐—ถ๐˜‚๐—บ ๐˜„๐—ฎ๐˜€ ๐—ผ๐—ฟ๐—ด๐—ฎ๐—ป๐—ถ๐˜€๐—ฒ๐—ฑ ๐—ฎ๐—ป๐—ฑ ๐—ณ๐˜‚๐—ป๐—ฑ๐—ฒ๐—ฑ ๐—ฏ๐˜† ๐—•๐—ฟ๐—ถ๐˜€๐˜๐—ผ๐—น ๐— ๐˜†๐—ฒ๐—ฟ๐˜€ ๐—ฆ๐—พ๐˜‚๐—ถ๐—ฏ๐—ฏ. ๐—•๐— ๐—ฆ ๐—บ๐—ฒ๐—ฑ๐—ถ๐—ฐ๐—ถ๐—ป๐—ฒ๐˜€ ๐—ฎ๐—ป๐—ฑ/๐—ผ๐—ฟ ๐—ฝ๐—ฟ๐—ผ๐—ฑ๐˜‚๐—ฐ๐˜ ๐—ถ๐—ป๐—ณ๐—ผ๐—ฟ๐—บ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—บ๐—ฎ๐˜† ๐—ฏ๐—ฒ ๐—ฑ๐—ถ๐˜€๐—ฐ๐˜‚๐˜€๐˜€๐—ฒ๐—ฑ. IMM-GB-2300537 | Date of Prep: Jan 2024